W. Jeong, D. Osei-hyiaman, O. Park, J. Liu, S. Batkai et al., Paracrine Activation of Hepatic CB1 Receptors by??Stellate Cell-Derived Endocannabinoids Mediates??Alcoholic Fatty Liver, Cell Metabolism, vol.7, issue.3, pp.227-235, 2008.
DOI : 10.1016/j.cmet.2007.12.007

D. Osei-hyiaman, M. Depetrillo, P. Pacher, J. Liu, S. Radaeva et al., Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity, Journal of Clinical Investigation, vol.115, issue.5, pp.1298-1305, 2005.
DOI : 10.1172/JCI200523057

C. Hezode, E. Zafrani, F. Roudot-thoraval, C. Costentin, A. Hessami et al., Daily Cannabis Use: A Novel Risk Factor of Steatosis Severity in Patients With Chronic Hepatitis C, Gastroenterology, vol.134, issue.2, pp.432-439, 2008.
DOI : 10.1053/j.gastro.2007.11.039

S. Batkai, Z. Jarai, J. Wagner, S. Goparaju, K. Varga et al., Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis, Nature Medicine, vol.7, issue.7, pp.827-832, 2001.
DOI : 10.1038/89953

J. Ros, J. Claria, J. To-figueras, A. Planaguma, P. Cejudo-martin et al., Endogenous cannabinoids: A new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat, Gastroenterology, vol.122, issue.1, pp.85-93, 2002.
DOI : 10.1053/gast.2002.30305

B. Julien, P. Grenard, F. Teixeira-clerc, V. Nhieu, J. Li et al., Antifibrogenic role of the cannabinoid receptor CB2 in the liver, Gastroenterology, vol.128, issue.3, pp.742-755, 2005.
DOI : 10.1053/j.gastro.2004.12.050

J. Munoz-luque, R. J. Fernandez-varo, G. Tugues, S. Morales-ruiz, M. Alvarez et al., Regression of Fibrosis after Chronic Stimulation of Cannabinoid CB2 Receptor in Cirrhotic Rats, Journal of Pharmacology and Experimental Therapeutics, vol.324, issue.2, pp.475-483, 2008.
DOI : 10.1124/jpet.107.131896

V. Hegde, S. Hegde, B. Cravatt, L. Hofseth, M. Nagarkatti et al., Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids: Involvement of Regulatory T Cells, Molecular Pharmacology, vol.74, issue.1, pp.20-33, 2008.
DOI : 10.1124/mol.108.047035

N. Buckley, K. Mccoy, E. Mezey, T. Bonner, A. Zimmer et al., Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor, European Journal of Pharmacology, vol.396, issue.2-3, pp.141-149, 2000.
DOI : 10.1016/S0014-2999(00)00211-9

V. Serriere-lanneau, F. Teixeira-clerc, L. Li, M. Schippers, W. De-wries et al., The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing, The FASEB Journal, vol.21, issue.9, pp.2005-2013, 2007.
DOI : 10.1096/fj.06-6889com

URL : https://hal.archives-ouvertes.fr/inserm-00130028

A. Nicou, V. Serriere, M. Hilly, S. Prigent, L. Combettes et al., Remodelling of calcium signalling during liver regeneration in the rat, Journal of Hepatology, vol.46, issue.2, pp.247-256, 2007.
DOI : 10.1016/j.jhep.2006.08.014

L. Li, P. Grenard, J. Tran-van-nhieu, B. Julien, A. Mallat et al., Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts, Gastroenterology, vol.125, issue.2
DOI : 10.1016/S0016-5085(03)00906-5

R. Taub, Liver regeneration: from myth to mechanism, Nature Reviews Molecular Cell Biology, vol.135, issue.10, pp.836-847, 2004.
DOI : 10.1073/pnas.220430497

N. Fausto, J. Campbell, and K. Riehle, Liver regeneration, Hepatology, vol.151, issue.S1, pp.45-53, 2006.
DOI : 10.1002/hep.20969

L. Morio, H. Chiu, K. Sprowles, P. Zhou, D. Heck et al., Distinct Roles of Tumor Necrosis Factor-?? and Nitric Oxide in Acute Liver Injury Induced by Carbon Tetrachloride in Mice, Toxicology and Applied Pharmacology, vol.172, issue.1, pp.44-51, 2001.
DOI : 10.1006/taap.2000.9133

G. Aram, J. Potter, X. Liu, M. Torbenson, and E. Mezey, Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration, Hepatology, vol.32, issue.6, pp.2051-2058, 2008.
DOI : 10.1002/hep.22278

R. Rai, F. Lee, A. Rosen, S. Yang, H. Lin et al., Impaired liver regeneration in inducible nitric oxide synthase (iNOS) deficient mice, Gastroenterology, vol.114, pp.13829-13834, 1998.
DOI : 10.1016/S0016-5085(98)85380-8

Y. Kim, R. Talanian, and T. Billiar, Nitric Oxide Inhibits Apoptosis by Preventing Increases in Caspase-3-like Activity via Two Distinct Mechanisms, Journal of Biological Chemistry, vol.272, issue.49, pp.31138-31148, 1997.
DOI : 10.1074/jbc.272.49.31138

G. Michalopoulos, Liver regeneration, Journal of Cellular Physiology, vol.169, issue.2, pp.286-300, 2007.
DOI : 10.1002/jcp.21172

M. Bansal, K. Kovalovich, R. Gupta, W. Li, A. Agarwal et al., Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression, Journal of Hepatology, vol.42, issue.4, pp.548-556, 2005.
DOI : 10.1016/j.jhep.2004.11.043

S. Lotersztajn, B. Julien, F. Teixeira-clerc, P. Grenard, and A. Mallat, HEPATIC FIBROSIS: Molecular Mechanisms and Drug Targets, Annual Review of Pharmacology and Toxicology, vol.45, issue.1, pp.605-628, 2005.
DOI : 10.1146/annurev.pharmtox.45.120403.095906

S. Siegmund, T. Qian, S. De-minicis, J. Harvey-white, G. Kunos et al., The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species, The FASEB Journal, vol.21, issue.11, pp.2798-2806, 2007.
DOI : 10.1096/fj.06-7717com

Y. Avraham, O. Zolotarev, N. Grigoriadis, T. Poutahidis, I. Magen et al., Cannabinoids and Capsaicin Improve Liver Function Following Thioacetamide-Induced Acute Injury in Mice, The American Journal of Gastroenterology, vol.115, issue.12, pp.3047-3056, 2008.
DOI : 10.1111/j.1572-0241.2008.02155.x

K. Kovalovich, R. Deangelis, W. Li, E. Furth, G. Ciliberto et al., Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice, Hepatology, vol.102, issue.1, pp.149-159, 2000.
DOI : 10.1002/hep.510310123

B. Gao, Therapeutic potential of interleukin-6 in preventing obesity- and alcohol-associated fatty liver transplant failure, Alcohol, vol.34, issue.1, pp.59-65, 2004.
DOI : 10.1016/j.alcohol.2004.07.006

T. Luedde and C. Trautwein, Intracellular survival pathways in the liver, Liver International, vol.77, issue.10, pp.1163-1174, 2006.
DOI : 10.1038/nrc780

X. Jin, T. Zimmers, E. Perez, R. Pierce, Z. Zhang et al., Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair, Hepatology, vol.107, issue.3
DOI : 10.1002/hep.21087

M. Passino, R. Adams, S. Sikorski, and K. Akassoglou, Regulation of Hepatic Stellate Cell Differentiation by the Neurotrophin Receptor p75NTR, Science, vol.315, issue.5820, pp.1853-1856, 2007.
DOI : 10.1126/science.1137603

V. Kalinichenko, D. Bhattacharyya, Y. Zhou, G. Gusarova, W. Kim et al., Foxf1 +/??? mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl4 injury, Hepatology, vol.128, issue.1, pp.107-117, 2003.
DOI : 10.1053/jhep.2003.50005

S. Sanz, J. Pucilowska, S. Liu, C. Rodriguez-ortigosa, P. Lund et al., Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury, Gut, vol.54, issue.1, pp.134-141, 2005.
DOI : 10.1136/gut.2003.024505

N. Trim, S. Morgan, M. Evans, R. Issa, D. Fine et al., Hepatic Stellate Cells Express the Low Affinity Nerve Growth Factor Receptor p75 and Undergo Apoptosis in Response to Nerve Growth Factor Stimulation, The American Journal of Pathology, vol.156, issue.4, pp.1235-1243, 2000.
DOI : 10.1016/S0002-9440(10)64994-2